Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer.
Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer.
复制标题
特异性分子成像在HER2阳性乳腺癌中的临床前和临床应用。
DOI:
10.20892/j.issn.2095-3941.2017.0044
复制
发表时间:
2017-08
影响因子:
5.5
通讯作者:
Wang P
中科院分区:
文献类型:
--
作者:
Chen W;Li X;Zhu L;Liu J;Xu W;Wang P
Precision medicine and personalized therapy are receiving increased attention, and molecular-subtype classification has become crucial in planning therapeutic schedules in clinical practice for patients with breast cancer. Human epidermal growth factor receptor 2 (HER2) is associated with high-grade breast tumors, high rates of lymph-node involvement, high risk of recurrence, and high resistance to general chemotherapy. Analysis of HER2 expression is highly important for doctors to identify patients who can benefit from trastuzumab therapy and monitor the response and efficacy of treatment. In recent years, significant efforts have been devoted to achieving specific and noninvasive HER2-positive breast cancer imaging in vivo. In this work, we reviewed existing literature on HER2 imaging in the past decade and summarized the studies from different points of view, such as imaging modalities and HER2-specific probes. We aimed to improve the understanding on the translational process in molecular imaging for HER2 breast cancer.
登录
查看更多内容
影响因子:
14
作者:
Chen, Chuang;Peng, Jun;Li, Yan
通讯作者:
Li, Yan
影响因子:
3.1
作者:
Honarvar, Hadis;Jokilaakso, Nima;Jarver, Peter
通讯作者:
Jarver, Peter
影响因子:
9.3
作者:
Dijkers, Eli C. F.;Kosterink, Jos G. W.;Lub-de Hooge, Marjolijn N.
通讯作者:
Lub-de Hooge, Marjolijn N.
影响因子:
2.8
作者:
Gaykema, Sietske B. M.;de Jong, Johan R.;Lub-de Hooge, Marjolijn N.
通讯作者:
Lub-de Hooge, Marjolijn N.
影响因子:
8.9
作者:
d'Amico, Andrea
通讯作者:
d'Amico, Andrea